Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Basler

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|August 18, 2025
The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentationNatalie Pach, Sarah Ochs, Jinjing Cao, et al.
Frontiers in Immunology|June 17, 2022
Immunoproteasome Inhibition Reduces the T Helper 2 Response in Mouse Models of Allergic Airway InflammationFranziska Oliveri, Michael Basler, Tata Nageswara Rao, et al.
Nucleic Acids Research|October 18, 2023
scTEA-db: a comprehensive database of novel terminal exon isoforms identified from human single cell transcriptomesMiguel Barquin, Ian U Kouzel, Beat Ehrmann, et al.
Iscience|June 23, 2025
Stress transmission in social groups of mice: unveiling physiological responses, behavioral patterns, and immune dynamicsDennis Horvath, Dennis Mink, Kritika Saxena, et al.
Kidney International|December 13, 2017
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantationJun Li, Michael Basler, Gerardo Alvarez, et al.
Life Science Alliance|April 3, 2023
The ubiquitin-like modifier FAT10 is degraded by the 20S proteasome in vitro but not in celluloFranziska Oliveri, Steffen Johannes Keller, Heike Goebel, et al.
Kidney International|January 28, 2019
Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factorsJun Li, Julia Koerner, Michael Basler, et al.
Immunogenetics|March 7, 2018
The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functionsRichard Schregle, Mei Min Mah, Stefanie Mueller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2015
The Ubiquitin-like Modifier FAT10 Is Selectively Expressed in Medullary Thymic Epithelial Cells and Modifies T Cell SelectionStefanie Buerger, Valerie L Herrmann, Sarah Mundt, et al.
Frontiers in Immunology|April 3, 2026
Intact lymph node homing and CD8<sup>+</sup> T-cell priming abilities of Sprouty2-deficient dendritic cellsNadine Anslinger, Guerric P B Samson, Vladimir Purvanov, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|August 18, 2025
The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentationNatalie Pach, Sarah Ochs, Jinjing Cao, et al.
Frontiers in Immunology|June 17, 2022
Immunoproteasome Inhibition Reduces the T Helper 2 Response in Mouse Models of Allergic Airway InflammationFranziska Oliveri, Michael Basler, Tata Nageswara Rao, et al.
Nucleic Acids Research|October 18, 2023
scTEA-db: a comprehensive database of novel terminal exon isoforms identified from human single cell transcriptomesMiguel Barquin, Ian U Kouzel, Beat Ehrmann, et al.
Iscience|June 23, 2025
Stress transmission in social groups of mice: unveiling physiological responses, behavioral patterns, and immune dynamicsDennis Horvath, Dennis Mink, Kritika Saxena, et al.
Kidney International|December 13, 2017
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantationJun Li, Michael Basler, Gerardo Alvarez, et al.
Life Science Alliance|April 3, 2023
The ubiquitin-like modifier FAT10 is degraded by the 20S proteasome in vitro but not in celluloFranziska Oliveri, Steffen Johannes Keller, Heike Goebel, et al.
Kidney International|January 28, 2019
Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factorsJun Li, Julia Koerner, Michael Basler, et al.
Immunogenetics|March 7, 2018
The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functionsRichard Schregle, Mei Min Mah, Stefanie Mueller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2015
The Ubiquitin-like Modifier FAT10 Is Selectively Expressed in Medullary Thymic Epithelial Cells and Modifies T Cell SelectionStefanie Buerger, Valerie L Herrmann, Sarah Mundt, et al.
Frontiers in Immunology|April 3, 2026
Intact lymph node homing and CD8<sup>+</sup> T-cell priming abilities of Sprouty2-deficient dendritic cellsNadine Anslinger, Guerric P B Samson, Vladimir Purvanov, et al.
Pageof 8